biote Corp. (BTMD): Long-Term Debt

Annual figures by period end, from SEC filings.

$103.12M
As of 2025-12-31
$125.00M
As of 2026-06-30
-5.4%
3-year compound annual growth
$121.88M2022-12-31: $121.88M2023-12-31: $115.62M2024-12-31: $109.38M2025-12-31: $103.12M$103.12M
2022-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$103.12M-5.7%2026-03-13, Balance as of period end
2024-12-31$109.38M-5.4%2025-03-14, Balance as of period end
2023-12-31$115.62M-5.1%2024-03-15, Balance as of period end
2022-12-31$121.88Mn/a2023-03-29, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
biote Corp. (BTMD)2025-12-31$103.12M-5.7%
Glass House Brands Inc. (GLAS)2025-12-31$68.67M+18.0%
Marimed Inc. (MRMD)2025-12-31$76.04M-2.7%
Jushi Holdings Inc. (JUSH)2025-12-31$205.83M+10.5%
Mannatech Inc (MTEX)2025-12-31$2.75Mn/a
Fitlife Brands, Inc. (FTLF)2024-12-31$13.12M-34.8%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$319.52M+3.7%
Trulieve Cannabis Corp. (TRLV)2025-12-31$136.74M-62.5%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$548.65M-3.5%

Compare BTMD, GLAS, MRMD, JUSH side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗